NCT02700373View on ClinicalTrials.gov

A Phase I, Single-Center Study of PDC-APB in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions
Contact Dermatitis
Interventions
DRUG

PDC-APB

DRUG

Placebo

Trial Locations (1)

37064

Clinical Research Solutions, Franklin

Sponsors
All Listed Sponsors
lead

Hapten Sciences, Inc.

INDUSTRY